Medlab Middle East 2025 Opens with Groundbreaking Innovations
By LabMedica International staff writers Posted on 03 Feb 2025 |

The 24th edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, is being held at Dubai World Trade Centre from 3-6 February. Organized by Informa Markets (London, UK), the event themed ‘Empowering today’s medical labs for tomorrow’s future’ features over 800 exhibitors from 40 countries, with 20,000 visitors exploring the latest technology and updates for the laboratory industry. Medlab Middle East showcases the latest innovations and technologies across eight dynamic product categories, which include disposables and consumer goods, emergency medicine, imaging and diagnostics, healthcare and general services, IT, laboratory, medical equipment and devices, and pharma and nutrition.
The 24th edition builds on the success of Medlab Middle East 2024 when the event generated an estimated business value of USD 670 million, fueling medical laboratory growth across the Middle East and beyond. The event features the most prominent names in the industry, with key exhibitors showcasing their innovations including Snibe, PureLab, World Data Exchange, Merck and Abbott. The world’s only multidisciplinary congress in the medical laboratory industry, the Medlab Middle East Congress returns with 12 CME-accredited conferences in Lab Management, Clinical Chemistry, Lab Quality, Hematology, Clinical Microbiology, Molecular Diagnostics, Blood Transfusion Medicine and Cellular Therapy, Histopathology, Lab Sustainability and Immunology. A new Lab Automation conference debuts this year, designed to explore the transformative impact of automation and IT workflows on laboratory operations.
The Congress features 150 local and international speakers and 60 VIP guests and is expected to draw over 4,000 delegates from the medical and laboratory fields. Key topics explored at the event include ‘The role of laboratory leadership to prepare laboratories for outbreak detection’, ‘Advances in stem cell therapy’ and ‘The past and the future for biomedical sciences and career options for the next generation’. Medlab Middle East 2025 is introducing two new leadership forums dedicated to women’s health and precision medicine. The Women’s Health Leadership Forum, held on the opening day of Medlab Middle East, aims to enhance women’s health through laboratory diagnostics. The event showcases cutting-edge innovations, addresses key challenges and uncovers collaboration opportunities that will enhance diagnostic capabilities for addressing women’s health needs.
The Precision Medicine Leadership Forum, featuring precision medicine experts, aims to offer insights from top experts in precision medicine, fostering a dialogue around cutting-edge innovations in genetics, personalized healthcare and new targeted therapies shaping the future of patient care. The program includes sessions on how genetic data is being integrated into treatment plans and the impact of precision medicine on improving patient care, among several other key topics in the precision medicine field. Also new for the 2025 edition, the Global Lab Leaders Breakfast Forum unites Medlab portfolio global advisers, scientific chairs, international partners and stakeholders in an exclusive, invitation-only dialogue, concentrating on topics that are crucial to advancing laboratory practices worldwide. The GCC Lab Leaders Breakfast Forum will see a gathering of officials, experts, and specialists from both public and private sector laboratories, as well as national standardization bodies across the GCC region. The event aims to foster collaboration and open dialogue on critical topics, including laboratory management, quality assurance, and proficiency testing. The ABCHealth Session at Medlab Middle East explores the transformative role of AI and advanced technologies in reshaping diagnostic business models across Africa.
“The 2025 edition of Medlab Middle East promises to be a landmark event which spotlights cutting-edge advancements and sustainable practices in laboratory medicine,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a unique opportunity to connect with a diverse range of companies and professionals in the medical laboratory industry, opening doors to new networks and opportunities for growth.”
Latest MEDLAB 2025 News
- Medlab Middle East Rebranded to WHX Labs Dubai
- BIOBASE Showcases Comprehensive Range of Laboratory Solutions
- Dymind Presents Advanced Automatic Hematology Analysis Line
- BioPerfectus Presents Latest Solutions for Women's Health and Infectious Disease Diagnosis
- YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency
- Vazyme Showcases Cutting-Edge Microfluidic Solutions for Precise and Efficient Laboratory Workflows
- Erba Unveils New H 7100 Advanced Hematology Analyzer
- HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments
- Tianlong Presents Advanced Instruments and Cutting-Edge Reagents
- Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes
- DRG Unveils Innovative Traumatic Brain Injury (TBI) Test Panel
- Fapon Presents Comprehensive Range of One-Stop IVD Solutions
- Anbio Biotechnology Showcases Cutting-Edge Diagnostic Solutions
- Sysmex Showcases Latest Laboratory Innovations and Technologies
- Sansure Presents Advanced Diagnostic Solutions
- Snibe Demonstrates Cutting-Edge Diagnostic Solutions
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more